Top Industry Leaders in the Gene Synthesis Market
Latest Gene Synthesis Companies Update:
Twist Bioscience Announced a strategic partnership with Bayer in October 2023 for antibody discovery using Twist's DNA synthesis and high-throughput screening technologies.
DNA Script Launched the SYNTAX system in early access for select customers in April 2023, offering an enzymatic DNA synthesis platform for on-demand gene assembly.
ATUM (formerly DNA2.0) Raised USD 100 million in Series D funding in May 2023 to expand its gene synthesis and synthetic biology capabilities.
GeneArt (part of Thermo Fisher Scientific) Unveiled their GeneOptimizer™ software in September 2023, helping researchers design and optimize synthetic gene sequences for improved expression.
GeneWiz Established a new gene synthesis facility in China in August 2023, expanding its global manufacturing capacity.
List of Gene Synthesis Key companies in the market
- Thermo Fisher Scientific, Inc (US)
- GenScript (US)
- Genewiz (US)
- Boster Biological Technology (US)
- Twist Bioscience (US)
- ProMab Biotechnologies, Inc. (US)
- Eurofins Genomics (US)
- Integrated DNA Technologies, Inc. (US)
- OriGene Technologies, Inc. (US)
- BioCat GmbH (Germany)